Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Also, the Biden administration releases 2 new reports on long COVID.
Infection rate fell from 20% to 7% after 4 doses in one study, and 3 doses increased protection by a third in 2 other studies.
Dynamic restrictions on nonessential foreign travel into Canada helped slow COVID-19 variant introductions in early 2020 and 2021, allowing the government more time to scale up vaccination, testing, and contact tracing programs, according to a study published yesterday in eLife.
A total of 33% of young kids and 39% of those 11 to 17 had high Problematic Media Use Measure scores.
More than half of high-risk SARS-CoV-2 Omicron inpatients or outpatients given the monoclonal antibody sotrovimab rapidly developed viral spike-protein mutations linked to treatment resistance, according to a study from the Netherlands published yesterday in JAMA.
Nursing homes in US states with COVID-19 vaccine mandates for healthcare workers saw a 7 percentage-point increase in staff vaccine uptake over homes in non-mandate states during a 5-month period in 2021, with no worsening of worker shortages, finds a study published late last week in JAMA Health Forum.
The authors said it's not clear if reduced severity stemmed from vaccination or from Omicron characteristics.
Rebound has also been seen in untreated people and in those who took molnupiravir, and the bottom line is treatments cut severe outcomes.
COVID-19 patients who have a stroke are more than twice as likely to die than uninfected stroke patients and are often younger and healthier, finds research presented yesterday at the Society of NeuroInterventional Surgery’s (SNIS's) 19th Annual Meeting in Toronto.
Vaccine contracts with both Moderna and Pfizer come ahead of booster dose campaigns expected to begin in September.
